跳至主要内容
临床试验/NCT02017314
NCT02017314Unknown4 期

Correlation of Postoperative VAS Values and Body Mass Index in Patients Undergoing Abdominal Surgery: A Clinical Trial

Istanbul University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
Pain Scores on the Visual Analog Scale

研究概览

简要总结

The aim of the study is to observe if any correlation between Body mass index and VAS values exists in patients who has gone under abdominal surgery.

Group I : Patients with BMI<30 Group II: Patients with BMI between 30 and 34.9 Group III: Patients with BMI between 35 and 39.9 Group IV: Patients with BMI between 40 and 49.9 Group V : Patients with BMI >50

After the end of surgery patients will be extubated and in the recovery room morphine PCA (patient-controlled analgesia) treatment will be started according to their adjusted body weight. When VAS values over 4,10 mg/kg Paracetamol IV will be used as an escape treatment. VAS values and Delivery and Demand of the PCA and additional need for analgesics will be recorded in the first 48 hours.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing abdominal surgery and who will be given PCA treatment for postoperative pain.

排除标准

  • patients younger than 18 years old, patients with uncompensated diabetes or related polyneuropathy, patients receiving antidepressants or have a diagnosis of depression

研究组 & 干预措施

Group 5

Active Comparator

Patients with BMI > 50

干预措施: Morphine (Drug)

Group IV

Active Comparator

Patients with BMI between 40 and 49.9

干预措施: Morphine (Drug)

Group III

Active Comparator

Patients with BMI between 35 and 39.9

干预措施: Morphine (Drug)

Group II

Active Comparator

patients with BMI between 30 and 34.9

干预措施: Morphine (Drug)

Group I

Active Comparator

Patients with BMI <30

干预措施: Morphine (Drug)

结局指标

主要结局

Pain Scores on the Visual Analog Scale

时间窗: 48 hours

Correlation between the VAS Scores and BMI will evaluated

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Guniz M.Koksal

Assc.Prof

Istanbul University

研究点 (1)

Loading locations...

相似试验